| Name | VPC-13566 |
|---|
| Description | VPC-13566 is an advanced BF3-specific small molecule that was previously reported to effectively inhibit AR transcriptional activity and to displace the BAG1L peptide from the BF3 pocket. VPC-13566 inhibits the growth of various prostate cancer cell lines, including an enzalutamide-resistant cell line, and reduces the growth of AR-dependent prostate cancer xenograft tumors in mice. |
|---|
| Molecular Formula | C18H14N2 |
|---|---|
| Molecular Weight | 258.32 |